| Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis | |
| Du, Heyue; Li, Xiaodan; Su, Na; Li, Ling; Hao, Xiaoting; Gao, Haihui; Kwong, Joey Sum-Wing; Vandvik, Per Olav; Yang, Xueli; Nemeth, Imola | |
| 2019 | |
| 卷号 | 105期号:15页码:1149-1159 |
| 关键词 | cardiovascular disease low-density lipoprotein cholesterol lipid-lowering drugs proprotein convertase subtilisin kexin type 9 inhibitors systematic review |
| ISSN号 | 1355-6037 |
| DOI | 10.1136/heartjnl-2019-314763 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6344253 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Du, Heyue,Li, Xiaodan,Su, Na,et al. Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis[J],2019,105(15):1149-1159. |
| APA | Du, Heyue.,Li, Xiaodan.,Su, Na.,Li, Ling.,Hao, Xiaoting.,...&Li, Sheyu.(2019).Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis.,105(15),1149-1159. |
| MLA | Du, Heyue,et al."Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis".105.15(2019):1149-1159. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论